HW071021 Monotherapy in Patients With Advanced Solid Tumors
NCT06882135
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
HW071021 Tablets
Sponsor
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company